These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 6603298)

  • 1. High levels of complement breakdown products in tuberculous pleural effusions.
    Lew DP; Perrin LH; Vassalli JD; Suter S; Lambert PH; Waldvogel FA
    Clin Exp Immunol; 1983 Jun; 52(3):569-74. PubMed ID: 6603298
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Activation of the alternative complement pathway in pleural fluid of patients with pneumonia].
    Aguado MT; Celada A
    Allergol Immunopathol (Madr); 1982; 10(3):215-20. PubMed ID: 6924537
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Decreased heat-labile opsonic activity and complement levels associated with evidence of C3 breakdown products in infected pleural effusions.
    Lew PD; Zubler R; Vaudaux P; Farquet JJ; Waldvogel FA; Lambert PH
    J Clin Invest; 1979 Feb; 63(2):326-34. PubMed ID: 429556
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Loculated pleural empyema: identification of complement breakdown products in contiguous sterile pleural fluid.
    Lew PD; Perrin LH; Waldvogel FA; Lambert PH
    Scand J Infect Dis; 1982; 14(3):225-9. PubMed ID: 6924409
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Comparison of complement activation between tuberculous and malignant pleuritis].
    Hidaka K; Abe M; Tanaka T; Mitsuyama T; Hara N; Hara N
    Nihon Kyobu Shikkan Gakkai Zasshi; 1995 Apr; 33(4):379-83. PubMed ID: 7791265
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Immunologic study of pleural neoplastic effusions: Detection of immune complexes and complement activation].
    Kaelin R; Docquier C; Lew D; Carpentier N; Lambert PH; Waldvogel FA
    Schweiz Med Wochenschr; 1978 Dec; 108(49):1971-3. PubMed ID: 749195
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Complement components and their activation products in pleural fluid.
    Salomaa ER; Viander M; Saaresranta T; Terho EO
    Chest; 1998 Sep; 114(3):723-30. PubMed ID: 9743157
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Demonstration of a local exhaustion of complement components and of an enzymatic degradation of immunoglobulins in pleural empyema: a possible factor favouring the persistence of local bacterial infections.
    Lew DP; Despont JP; Perrin LH; Aguado MT; Lambert PH; Waldvogel FA
    Clin Exp Immunol; 1980 Dec; 42(3):506-14. PubMed ID: 6908546
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Alternative pathway complement activation in rheumatoid arthritis.
    El-Ghobarey A; Whaley K
    J Rheumatol; 1980; 7(4):453-60. PubMed ID: 6158571
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Complement components in Nigerians with bronchial asthma.
    Onyemelukwe GC
    Ann Allergy; 1989 Oct; 63(4):309-12. PubMed ID: 2802267
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [C3, C4, factor B components in septic states].
    Laurent P; Goudot B; Grozel JM
    Nouv Presse Med; 1978 Jul 1-8; 7(27):2406. PubMed ID: 673827
    [No Abstract]   [Full Text] [Related]  

  • 12. [Lymphocyte chemotactic factor in tuberculous pleural effusion].
    Naito T; Ohtsuka M; Ishikawa H; Satoh H; Hasegawa S
    Kekkaku; 1998 Apr; 73(4):307-14. PubMed ID: 9613051
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Components C3, C4 and B factor of complement system in the course of septic states of different levels of seriousness (author's transl)].
    Goudot-Patay B; Laurent P; Grozel JM
    Anesth Analg (Paris); 1979; 36(7-8):301-6. PubMed ID: 525835
    [No Abstract]   [Full Text] [Related]  

  • 14. Inhibition of human factor B activity of the properdin system by human and guinea-pig sera.
    Lambré C
    Ann Immunol (Paris); 1979; 130C(1):71-8. PubMed ID: 373582
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Diagnostic value of complement components in pleural fluid: report of 135 cases.
    Shitrit D; Ollech JE; Ollech A; Peled N; Amital A; Fox B; Kramer MR
    Respir Med; 2008 Nov; 102(11):1631-5. PubMed ID: 18653322
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Determination of the alternative complement pathway in patients with amebic liver abscess].
    Capin MR; Jiménez M; Zamacona G; Ortíz-Ortíz L
    Arch Invest Med (Mex); 1978; 9 Suppl 1():297-302. PubMed ID: 697476
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Response of the alternative complement pathway to an oral fat load in first-degree relatives of subjects with type II diabetes.
    Peake PW; Kriketos AD; Campbell LV; Charlesworth JA
    Int J Obes (Lond); 2005 Apr; 29(4):429-35. PubMed ID: 15111984
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association between inflammatory mediators and the fibrinolysis system in infectious pleural effusions.
    Alemán C; Alegre J; Monasterio J; Segura RM; Armadans L; Anglés A; Varela E; Ruiz E; Fernández de Sevilla T
    Clin Sci (Lond); 2003 Nov; 105(5):601-7. PubMed ID: 12826021
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The analysis of the complement activation product SC5 b-9 is applicable in neonates in spite of their profound C9 deficiency.
    Høgåsen AK; Overlie I; Hansen TW; Abrahamsen TG; Finne PH; Høgåsen K
    J Perinat Med; 2000; 28(1):39-48. PubMed ID: 10765513
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Paroxysmal nocturnal hemoglobinuria. Increase in proteins of the alternative complement pathway].
    de Gramont A; Kazatchkine M; Maillet F; Blanche M; Debray J
    Presse Med; 1983 Mar; 12(12):747-50. PubMed ID: 6220312
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.